Records newly obtained by Rise for Animals and The Marty Project confirm what we’ve long suspected—and projected: Ridglan’s grip is slipping under the weight of public exposure.
In 2025, Ridglan Farms’ interstate dog sales appear to have fallen well short of past years—marking the steepest decline yet in its national trafficking of beagles for research and testing.*
Between 2024 and 2025, Wisconsin’s interstate sales records suggest a nearly 30% reduction in Ridglan’s dog sales, with its total 2025 interstate sales appearing—as we predicted based on mid-year sales records—to fall well short of 1,500 dogs:
This sharp decline follows an approximately 20% drop between 2023 and 2024, as well as an estimated 7% drop between 2022 and 2023.
In all, Ridglan’s documented dog sales appear to have fallen by more than 45% over the last three years.
And it’s not just smaller transactions—it’s fewer shipments, too:
Importantly, this downturn in demand does not appear linked to lack of “supply.”
Just last week, a Ridglan spokesperson told FOX6 Investigators that it still has 2,200 dogs on-site.
Rather, this is what the slow collapse of a violent enterprise looks like.
Not a clean implosion—at least not yet—but a steady unraveling. A slow bleed of cover, of legitimacy, of demand.
And, this was already in process before October 28, 2025, when Wisconsin’s Special Prosecutor confirmed evidence of felonious conduct at Ridglan and struck a formal agreement requiring the company to stop selling dogs for research by July 2026.
Yet, since then, Ridglan has still managed to sell at least 140 dogs—roughly 11% of its total 2025 interstate sales—to a handful of shameless, repeat customers:
- TRS Labs;
- IIT Research Institute;
- Midwest Veterinary Services; and
- East Tennessee Clinical Research.
(The last one—East Tennessee Clinical Research—isn’t just a loyal buyer. It’s a public defender of Ridglan . . . and a very recent recipient of an official federal warning for failing to provide even the most basic care to dogs in its facility.)
The records reveal these buyers as more than customers—as enablers, apologists, profiteers—doing what they can to squeeze every last drop of suffering from Ridglan’s final months.
But, these records reveal something else, too:
Hope.
Ridglan’s decline isn’t theoretical—it’s unfolding in real time.
Its sales are shrinking.
Its reputation is in freefall.
And its time is almost up.
Ridglan’s violent breeding operation is on borrowed time. And that means one thing:
A future without Ridglan-bred dogs locked in labs across the country isn’t only possible—it’s within reach.
*Earlier years in this dataset include some intrastate transactions, which are not required to be reported to state authorities. Because intrastate sales likely occurred in all years but are inconsistently documented, sales totals across years should be understood as reflecting different levels of reporting coverage rather than complete or directly comparable measures of total activity. This absence of comprehensive reporting means that documented sales figures represent minimum observable activity, not true totals.